Hepatomas with activating Ctnnb1 mutations in 'Ctnnb1-deficient' livers: a tricky aspect of a conditional knockout

Shigeki Sekine1, Reiko Ogawa, Yae Kanai

  • 1Pathology Division, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan 104-0045. ssekine@ncc.go.jp

Carcinogenesis
|January 11, 2011
PubMed

Insights

Hepatocyte-specific knockout mice using the Cre-loxP system show declining gene deletion efficiency over time. Aged mice develop tumors with reactivated beta-catenin signaling due to mutations, not recombination loss.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Conditional knockout mice, particularly using the Cre-loxP system, are vital for studying organ-specific gene functions.
  • Efficient hepatocyte-specific gene knockout models are widely used, but long-term recombination stability is often overlooked.

Purpose of the Study:

  • To evaluate the long-term stability of recombination efficiency in hepatocyte-specific Ctnnb1 (beta-catenin) knockout mice.
  • To investigate the consequences of declining recombination efficiency on liver tissue and tumor development over time.

Main Methods:

  • Utilized Alb-Cre;Ctnnb1flox/flox mice to create hepatocyte-specific beta-catenin knockouts.
  • Analyzed liver tissues from mice of different ages (2 months and 1 year) to assess recombination efficiency.
  • Performed sequencing to identify genetic alterations in tumors.

Main Results:

  • Efficient beta-catenin deletion in hepatocytes was observed at 2 months of age.
  • Aged mice (1 year) showed reappearance and expansion of beta-catenin-expressing hepatocytes, particularly in pericentral regions.
  • Hepatocellular adenomas and carcinomas developed in aged knockout mice, characterized by beta-catenin positivity, glutamine synthetase/Slc1a2 overexpression, and activating Ctnnb1 mutations.

Conclusions:

  • Long-term stability of Cre-loxP-mediated recombination in hepatocyte-specific knockout models requires careful age-dependent evaluation.
  • Activating mutations in the target gene can occur, leading to tumor formation, and should be considered as a potential artifact of the Cre-loxP system.